Yes. In the UK, eplerenone is approved as an adjunctive therapy for essential hypertension when blood pressure remains uncontrolled with first-line agents. It is typically added after an ACE inhibitor, ARB, calcium-channel blocker, or thiazide diuretic has been tried.
Both are aldosterone antagonists, but eplerenone is more selective for the mineral-corticoid receptor, resulting in a lower incidence of hormonal side effects such as gynecomastia and menstrual irregularities. Spironolactone may be preferred when a less selective agent is needed, while eplerenone is chosen for its better tolerability profile.
Blood-pressure-lowering effects can be observed within a few days of starting therapy, though the full benefit may take several weeks as fluid balance stabilises. Regular monitoring is recommended to assess response.
Patients should moderate foods high in potassium (e.g., bananas, oranges, potatoes) while on eplerenone, as the drug reduces potassium excretion. Dietary counseling helps avoid hyperkalemia, especially in those with reduced kidney function.
Yes. By lowering blood pressure, eplerenone can cause orthostatic hypotension, leading to light-headedness on standing. Rising slowly and staying hydrated can reduce this risk.
Your surgeon may advise withholding eplerenone 24-48 hours before major surgery to minimise the risk of intra-operative hyperkalemia and hypotension. Always follow the specific instructions given by your peri-operative team.
Because both drugs increase potassium, serum potassium and renal function should be checked within 1-2 weeks after starting the combination and periodically thereafter. Prompt dose adjustment is essential if potassium rises above 5.0 mmol/L.
Eplerenone is primarily metabolised by the liver, but no dose adjustment is routinely required for mild hepatic impairment. Severe liver disease, however, may affect drug clearance and should be evaluated by a clinician.
Eplerenone is usually taken once daily; the time (morning or evening) can be chosen based on patient convenience or to align with other once-daily medications. Consistency helps maintain stable blood levels.
Do not flush tablets down the toilet. Return them to a pharmacy’s take-back program or follow the NHS “Safe Disposal” guidelines, which recommend sealing them in a container and placing them in household waste only when a take-back option is unavailable.
Eplerenone is a prescription-only medication classified under the Heart & Blood Pressure therapeutic category. It is a selective aldosterone antagonist available in pill form, with the strengths 25 mg and 50 mg. In the United Kingdom, eplerenone is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) and is prescribed for conditions such as hypertension and certain forms of chronic heart failure.
Eplerenone blocks the binding of aldosterone-a hormone that promotes sodium retention and potassium excretion-to mineral-corticoid receptors in the distal nephron. By inhibiting this action, eplerenone:
The onset of action typically occurs within a few hours of dosing, with peak plasma concentrations reached in about 2-3 hours. The drug has an elimination half-life of approximately 4-6 hours, allowing once-daily dosing for most patients.
These indications are approved by the MHRA and reflected in the UK Summary of Product Characteristics (SPC) for eplerenone.
These effects are reported in more than 1 % of treated patients and are usually mild to moderate in intensity.
Patients should disclose all prescribed medicines, over-the-counter products, and herbal supplements to their healthcare provider before starting eplerenone.
If hyperkalemia or renal function deterioration is detected, dose reduction, temporary interruption, or discontinuation may be necessary.
This article provides educational information about eplerenone and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
